| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/06/2009 | US7473419 Intravascular delivery of nucleic acid |
| 01/06/2009 | CA2421267C Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 01/06/2009 | CA2387058C Injection vehicle for polymer-based formulations |
| 01/06/2009 | CA2348084C Crystallisation using supercritical or subcritical fluids |
| 01/06/2009 | CA2347979C Treatment of skin with adenosine or adenosine analog |
| 01/06/2009 | CA2344470C Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues |
| 01/06/2009 | CA2340921C Use of taxanes to treat brain cancer |
| 01/06/2009 | CA2340238C Improved stability for injection solutions |
| 01/06/2009 | CA2336772C Anticariogenic dairy product and its use |
| 01/06/2009 | CA2305341C Stabilization of envelope glycoprotein trimers by disulfide bonds introduced into a gp41 glycoprotein ectodomain |
| 01/06/2009 | CA2293575C Controlled release microencapsulated ngf formulation |
| 01/06/2009 | CA2244512C Dietary supplements containing natural ingredients |
| 01/06/2009 | CA2213519C Suksdorfin analogs, compositions thereof, and methods for making and using thereof |
| 01/06/2009 | CA2158446C Nucleic acid coding for a tumor rejection antigen precursor |
| 01/06/2009 | CA2144406C Gene transcription and ionizing radiation: methods and compositions |
| 01/06/2009 | CA2117490C Purified vacuolating toxin from helicobacter pylori and methods to use same |
| 01/06/2009 | CA1341589C Methods and deoxyribonucleic acid for the preparation of tissue factor protein |
| 01/06/2009 | CA1341588C Human ifn-beta2/i1-6, its purification and use |
| 01/05/2009 | CA2593020A1 Medicament compounds |
| 01/02/2009 | DE60224401T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure |
| 01/01/2009 | US20090007281 Animal Model for Assessing Copd-Related Diseases |
| 01/01/2009 | US20090007280 Ange gene in atopy |
| 01/01/2009 | US20090005541 Gag binding protein |
| 01/01/2009 | US20090005534 Methods and Compositions for the Treatment of Gastrointestinal Disorders |
| 01/01/2009 | US20090005441 Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
| 01/01/2009 | US20090005432 Pharmaceutical compositions including low dosages of desmopressin |
| 01/01/2009 | US20090005347 Via bisphosphonate drug; for prophylaxis of cartilage destruction or chondrolysis associated with osteonecrosis and/or osteochondritis dissecans |
| 01/01/2009 | US20090005333 Reducing culling in herd animals growth hormone releasing hormone (ghrh) |
| 01/01/2009 | US20090005322 Physiologically- Active Composition Based on Collagen |
| 01/01/2009 | US20090005321 Phenylazetidinone Derivatives |
| 01/01/2009 | US20090005320 Compositions comprising amino acid bicarbonate and methods of use thereof |
| 01/01/2009 | US20090005319 Topical compositions for delaying ejaculation and methods of using the same |
| 01/01/2009 | US20090005318 Controlled release composition and method of producing the same |
| 01/01/2009 | US20090005317 Methods for treating a corneal disorder and promoting skin wound healing |
| 01/01/2009 | US20090005316 Alpha-conotoxin mii analogs |
| 01/01/2009 | US20090005315 Vip Fragments and Methods of Use |
| 01/01/2009 | US20090005314 Compositions and Methods for Modulating Pgc-1Alpha to Treat Neurological Diseases and Disorders |
| 01/01/2009 | US20090005313 Activatable clostridial toxins |
| 01/01/2009 | US20090005312 Novel glp-1 analogues linked to albumin-like agents |
| 01/01/2009 | US20090005311 Expression vector comprising nucleotide sequences coding fructooligosaccharide (FOS)-related protein for enhancing ability of probiotic bacteria to compete in the gastrointestinal tract of mammals |
| 01/01/2009 | US20090005310 (En) Pharmaceutical Composition for Treating Haemorrhagic Shock and its Consecutive Symptoms |
| 01/01/2009 | US20090005308 activins (ActRIIB), for modulating (promoting or inhibiting) growth of tissue such as bone, cartilage, muscle, fat, and/or neuronal tissue; fusion proteins which inhibit signaling by myostatin and/or growth differentiation factor 11 in cell-based assay; drug screening; pharmacokinetics |
| 01/01/2009 | US20090005307 Compositions and Methods for Detection of Colorectal Cancer |
| 01/01/2009 | US20090005306 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity |
| 01/01/2009 | US20090005305 Service for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using crt translocation |
| 01/01/2009 | US20090005304 Human KCNQ5 potassium channel, methods and compositions thereof |
| 01/01/2009 | US20090005303 Proteases from carica having mitogenic activity and their methods of use |
| 01/01/2009 | US20090005302 Method, apparatus, and compound for effecting localized, non-systemic, immunogenic treatment of cancer |
| 01/01/2009 | US20090005301 207 Human Secreted Proteins |
| 01/01/2009 | US20090005300 Antimicrobial Peptides and Methods of Use |
| 01/01/2009 | US20090005299 Method For Producing Carboxy-Terminal-Amidified Peptides |
| 01/01/2009 | US20090005298 Bone Sialoprotein Collagen-Binding Peptides |
| 01/01/2009 | US20090005297 Aprotinin Variants |
| 01/01/2009 | US20090005296 Ammonium/Ammonia Transporter |
| 01/01/2009 | US20090005295 Syndecans and angiogenesis |
| 01/01/2009 | US20090005294 Peptides for the Treatment of Cancer Associated with the Human Papilloma Virus (HPV) and Other Epithelial Tumors |
| 01/01/2009 | US20090005293 Methods and compositions for increasing the anaerobic working capacity in tissues |
| 01/01/2009 | US20090005292 Novel Peptides that Bind to the Erythropoietin Receptor |
| 01/01/2009 | US20090004733 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides, and uses thereof |
| 01/01/2009 | US20090004723 Methods and Compositions Concerning Poxviruses and Cancer |
| 01/01/2009 | US20090004719 Protein-protein interactions in human immunodeficiency virus |
| 01/01/2009 | US20090004696 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 01/01/2009 | US20090004674 ACPL-related assays |
| 01/01/2009 | US20090004672 17867, a novel human aminopeptidase |
| 01/01/2009 | US20090004669 Methods of diagnosing pre-eclampsia or eclampsia |
| 01/01/2009 | US20090004312 Use of Neurotoxin Therapy for Treatment of Urologic and Related Disorders |
| 01/01/2009 | US20090004298 Use of S-Nitrosothiol Signaling to Treat Disordered Control of Breathing |
| 01/01/2009 | US20090004283 Sustained Release Formulation Comprising Octreotide and Two or More Polylactide-Co-Glycolide Polymers |
| 01/01/2009 | US20090004279 Method For Improvement Of Tolerance For Therapeutically Effective Agents Delivered By Inhalation |
| 01/01/2009 | US20090004276 Novel injectable chitosan mixtures forming hydrogels |
| 01/01/2009 | US20090004275 Composition for Delivery of an Active Agent |
| 01/01/2009 | US20090004273 Polymeric device for controlled release of active agents |
| 01/01/2009 | US20090004272 Polymeric devices for controlled release of active agents |
| 01/01/2009 | US20090004269 Pharmaceutical Composition Comprising a Proton Pump Inhibitor and a Protein Component |
| 01/01/2009 | US20090004266 Nanoparticles for protein drug delivery |
| 01/01/2009 | US20090004264 Methods for treating and ameliorating the symptons of inflammatory bowel diseases |
| 01/01/2009 | US20090004260 Medicament comprising hgf gene |
| 01/01/2009 | US20090004253 Composite device for the repair or regeneration of tissue |
| 01/01/2009 | US20090004251 Bacteriocins and Novel Bacterial Strains |
| 01/01/2009 | US20090004243 Biodegradable triblock copolymers for implantable devices |
| 01/01/2009 | US20090004242 Coatings and Biomedical Implants Formed From Keratin Biomaterials |
| 01/01/2009 | US20090004240 Implants with a phosphazene-containing coating |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004233 Microencapsulating compositions, methods of making, methods of using and products thereof |
| 01/01/2009 | US20090004227 Peroral Vaccine Carrier System |
| 01/01/2009 | US20090004224 Activatable clostridial toxins |
| 01/01/2009 | US20090004217 for determining whether an animal is naturally-infected with Ehrlichia canis, or is either not infected or is vaccinated with an E. canis vaccine |
| 01/01/2009 | US20090004216 inducing an immunological response in an animal by administering to the animal an attenuated CSFV pestivirus, wherein the RNase activity of glycoprotein ERNS of the CSFV pestivirus is inactivated by a deletion of the second histidine of the conserved ERNS sequence RHEWNKHGWCNW |
| 01/01/2009 | US20090004212 Tumour vaccines for MUC1-positive carcinomas |
| 01/01/2009 | US20090004210 Method for Preventing and Treating Alzheimer's Disease |
| 01/01/2009 | US20090004208 Method for designing hypoallergenic molecules for use in allergy desensitization with lessened chance of anaphylaxis, or as vaccines against allergic reactions |
| 01/01/2009 | US20090004206 Polynucleotides and Polypeptide Sequences Involved in the Process of Bone Remodeling |
| 01/01/2009 | US20090004196 Method of inhibiting osteoclast activity |
| 01/01/2009 | US20090004195 Somatostatin receptor antagonists and glucose control or hypoglycemia |
| 01/01/2009 | US20090004193 Diagnostics and Therapeutics for Diseases Associated With Vasoactive Intestinal Peptide Receptor 1 (Vpac1) |
| 01/01/2009 | US20090004188 antibody that specifically binds to a human TNF Receptor in the BRAIN (TRAIN) polypeptide; useful in regulating cell differentiation, death, and survival |
| 01/01/2009 | US20090004181 Method for Modulating Appetite |
| 01/01/2009 | US20090004178 Pharmaceutical compound for blocking the crt or erp57 translocation |
| 01/01/2009 | US20090004177 Combination Treatment with t-PA Variant and Low Molecular Weight Heparin |
| 01/01/2009 | US20090004176 Non-neurotoxic plasminogen activating factors for treating of stroke |